For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260324:nRSX9125Xa&default-theme=true
RNS Number : 9125X Savills PLC 24 March 2026
SAVILLS PLC (THE "COMPANY")
NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRS AND CONNECTED PERSONS
The Company announces that it has received notification that Group Chief
Financial Officer Nick Sanderson purchased 11,909 Savills plc ordinary shares
of 2.5p each ("Ordinary Shares") at £8.34816 per share on 24 March 2026. As
a result, Mr Sanderson has a total beneficial interest in 11,909 Ordinary
Shares, representing 0.008% of the Company's issued share capital.
The information set out below is provided in accordance with the requirements
of Article 19 of the EU Market Abuse Regulation No 596/2014.
1. Details of the Director
(a) Name Nick Sanderson
2. Reason for the notification
(a) Position/ status Group Chief Financial Officer / Director
(b) Initial notification/ Amendment Initial notification
3. Details of the issuer
(a) Name Savills plc
(b) LEI 213800WXICGMBWHTA933
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
(a) Description of the Financial Instrument Savills plc Ordinary Shares of 2.5p each
(b) Identification code of the Financial Instrument GB00B135BJ46
(c) Nature of the transaction Purchase of Ordinary Shares
(d) Price(s) and volume(s) Price(s) Volume(s)
£8.34816 per share 11,909
(e) Aggregated information N/A
- Aggregated volume
- Price
(f) Date(s) of the transactions 24 March 2026
(g) Place of the transaction London Stock Exchange (XLON)
Name of contact and telephone number for queries:
C M Lee
Group Legal Director & Company Secretary
020 3107 5444
24 March 2026
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHKZGZFGDRGVZM
Copyright 2019 Regulatory News Service, all rights reserved